跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ambicaine - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ambicaine
Approved
STANDARD
Ambicaine
Zim Laboratories Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
3f6ea558b6274b9b
Company
Zim Laboratories Limited
Type
Standard
Approval Details
Approval Id
3f6ea558b6274b9b
Drug Approval Philippines Name
Ambicaine
Product Name
Ambicaine
Registration Number
DRP-5367-08
Brand Name
Ambicaine
Generic Name
Cefuroxime (as Axetil)
Dosage Form
Powder For Oral Suspension
Dosage Strength
250 mg/5 mL
Manufacturer
Zim Laboratories Limited
Trader
Rainbow Life Sciences Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Ambicare Pharmaceuticals Inc.
Issuance Date
29 January 2024
Expiry Date
30 June 2029
Pharmacologic Category
Antibacterial
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
3f6ea558b6274b9b
Type
Standard
Back to Philippines FDA Approvals